- Home
- NOTV vs IDR Comparison
NOTV vs IDR Comparison
Compare NOTV & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- IDR
- Stock Information
- Founded
- NOTV 1974
- IDR 1996
- Country
- NOTV United States
- IDR United States
- Employees
- NOTV N/A
- IDR N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- IDR Precious Metals
- Sector
- NOTV Health Care
- IDR Basic Materials
- Exchange
- NOTV Nasdaq
- IDR Nasdaq
- Market Cap
- NOTV 126.3M
- IDR 142.7M
- IPO Year
- NOTV 1997
- IDR N/A
- Fundamental
- Price
- NOTV $4.27
- IDR $11.21
- Analyst Decision
- NOTV Strong Buy
- IDR Strong Buy
- Analyst Count
- NOTV 3
- IDR 1
- Target Price
- NOTV $5.92
- IDR $14.00
- AVG Volume (30 Days)
- NOTV 1.2M
- IDR 128.7K
- Earning Date
- NOTV 02-05-2025
- IDR 11-04-2024
- Dividend Yield
- NOTV N/A
- IDR N/A
- EPS Growth
- NOTV N/A
- IDR 344.27
- EPS
- NOTV N/A
- IDR 0.52
- Revenue
- NOTV $490,739,000.00
- IDR $21,955,008.00
- Revenue This Year
- NOTV $7.14
- IDR $86.37
- Revenue Next Year
- NOTV $5.73
- IDR $11.11
- P/E Ratio
- NOTV N/A
- IDR $21.73
- Revenue Growth
- NOTV N/A
- IDR 64.93
- 52 Week Low
- NOTV $1.23
- IDR $5.66
- 52 Week High
- NOTV $11.42
- IDR $18.35
- Technical
- Relative Strength Index (RSI)
- NOTV 49.19
- IDR 53.86
- Support Level
- NOTV $3.87
- IDR $10.06
- Resistance Level
- NOTV $4.67
- IDR $10.81
- Average True Range (ATR)
- NOTV 0.54
- IDR 0.45
- MACD
- NOTV -0.10
- IDR 0.17
- Stochastic Oscillator
- NOTV 22.22
- IDR 93.27
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.